{"id":629375,"date":"2022-12-07T20:52:01","date_gmt":"2022-12-07T20:52:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=629375"},"modified":"2022-12-07T20:52:01","modified_gmt":"2022-12-07T20:52:01","slug":"praderwilli-syndrome-pws-market-to-exhibit-substantial-growth-during-the-forecast-period-20222032-predicts-delveinsight","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/praderwilli-syndrome-pws-market-to-exhibit-substantial-growth-during-the-forecast-period-20222032-predicts-delveinsight_629375.html","title":{"rendered":"Prader-Willi Syndrome (PWS) Market to Exhibit Substantial Growth During the Forecast Period (2022-2032), Predicts DelveInsight"},"content":{"rendered":"
\n
\"Prader-Willi<\/a><\/div>\n
\n
Delveinsight Business Research LLP<\/div>\n<\/div>\n<\/div>\n
The Prader-Willi Syndrome (PWS) market dynamics are expected to experience a positive shift in the coming years owing to the launch of upcoming therapies. The therapies under development are focused on novel approaches that will improve the disease condition.<\/div>\n

Amongst the present therapeutic class, hormone therapies hold the highest share amongst the other therapeutic options available for treating PWS. Increased awareness of the disease, assisted by organizational support and the promising pipeline of therapies, is expected to fuel market growth.<\/em><\/p>\n

DelveInsight’s “Prader-Willi Syndrome Market Insights, Epidemiology, and Market Forecast 2032<\/strong>” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Prader-Willi Syndrome market size, share, and trends in the seven major market (7MM) (i.e., the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).<\/p>\n

The Prader-Willi Syndrome market report covers emerging drugs, current treatment practices, market share of individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice\/algorithm, key drivers & barriers impacting the market growth, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. <\/p>\n

\"Prader-Willi<\/p>\n

Prader-Willi Syndrome: An Overview<\/strong><\/p>\n

According to the US National Library of Medicine, Prader-Willi syndrome is a complex genetic condition affecting many body parts. This condition is characterized by weak muscle tone (hypotonia), feeding difficulties, poor growth, and delayed development in infancy. Beginning in childhood, affected individuals develop an insatiable appetite, which leads to chronic overeating (hyperphagia) and obesity. Some people with Prader-Willi syndrome, particularly those with obesity, also develop type 2 diabetes (the most common form of diabetes).<\/p>\n

The disease occurs due to the loss of function of several genes in a particular region of chromosome number 15. Among these are genes that provide instructions for making molecules called small nucleolar RNAs (snoRNAs). Although considered a “rare” disorder, PWS is one of the most common conditions seen in genetic clinics and is the most common genetic cause of obesity that has been identified to date.<\/em><\/p>\n

Prader-Willi Syndrome Market Key Facts<\/strong><\/p>\n